🔗 Access the full report here:

The EURETINA Clinical Trends Series is a new initiative designed to turn large-scale survey data into actionable insights for retina specialists. The first issue focuses on Wet Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME)—two key therapeutic areas where real-world practice continues to evolve.

Featuring expert commentary from Dr. Sandrine Zweifel, this report examines how clinicians across regions are approaching diagnosis, treatment, and long-term management, while highlighting gaps between guidelines and day-to-day care.

In this issue, you’ll find insights on:

• How nAMD and DME are diagnosed and monitored in routine clinical settings

• Real-world anti-VEGF treatment strategies, including initiation and switching patterns

• Persistent unmet needs in current treatment paradigms

• Factors influencing treatment adherence and long-term patient outcomes

By combining survey-driven insights with expert interpretation, this report offers a practical snapshot of current practice—and points toward opportunities to optimize care for patients with nAMD and DME.